These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13052966)

  • 1. Studies on the pathogenesis and immunity of tularemia. I. The demonstration of a protective antibody in mouse serum.
    PANNELL L; DOWNS CM
    J Infect Dis; 1953; 92(2):195-204. PubMed ID: 13052966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histopathological studies on experimental immunity of tularemia with special reference to histological difference between immunity and interference phenomenon in tularemia].
    KIKUTA K
    Nihon Byori Gakkai Kaishi; 1961; 50():515-43. PubMed ID: 14455898
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allergic reaction of the skin as an indication to immunity in tularemia].
    KALITINA TA
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jun; 27(6):61-7. PubMed ID: 13353702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain aspects of immunity of tularemia].
    OLSUF'EV NG; DUNAEVA TN; TSVETKOVA EM
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Jun; 28(6):13-5. PubMed ID: 13497173
    [No Abstract]   [Full Text] [Related]  

  • 5. [Certain indices of immunity in children vaccinated against tularemia].
    PIOTROVSKAIA SA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 May; 29(5):129. PubMed ID: 13570525
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allergic skin tests as an index of immunity in tularemia].
    KALITINA TA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):16-21. PubMed ID: 13570390
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitularense serum; correlation between protective capacity for white rats and precipitable antibody content.
    FOSHAY L; RUCHMAN I; NICHOLES PS
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():21. PubMed ID: 20248526
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitularense serum; correlation between protective capacity for white rats and precipitable antibody content.
    FOSHAY L; RUCHMAN I; NICHOLES PS
    J Lab Clin Med; 1947 Mar; 32(3):332. PubMed ID: 20289818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis of experimental pulmonary tularemia in non-immunized and immunized animals].
    Vortel V; Fingerland A; Kyntera F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1972; 15(2):205-12. PubMed ID: 4209560
    [No Abstract]   [Full Text] [Related]  

  • 10. CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
    Powell HJ; Cong Y; Yu JJ; Guentzel MN; Berton MT; Klose KE; Murthy AK; Arulanandam BP
    Immunol Cell Biol; 2008; 86(6):515-22. PubMed ID: 18427567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on pathogenesis and immunity in tularemia; immunogenic properties for the white mouse of various strains of Bacterium tularense.
    DOWNS CM; WOODWARD JM
    J Immunol; 1949 Oct; 63(2):147-63. PubMed ID: 15390504
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity against tularemia: passive protection of mice by transfer of immune tissues.
    ALLEN WP
    J Exp Med; 1962 Feb; 115(2):411-20. PubMed ID: 13860583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT.
    Foshay L; Ruchman I; Nicholes PS
    J Clin Invest; 1947 Jul; 26(4):756-60. PubMed ID: 16695467
    [No Abstract]   [Full Text] [Related]  

  • 15. Adaptive Immunity to
    Roberts LM; Powell DA; Frelinger JA
    Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum immunoglobulin IgG subclass distribution of antibody responses to Francisella tularensis in patients with tularemia].
    Rastawicki W; Rokosz-Chudziak N; Wolaniuk N
    Med Dosw Mikrobiol; 2014; 66(1):11-5. PubMed ID: 25007508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
    EIGELSBACH HT; DOWNS CM
    J Immunol; 1961 Oct; 87():415-25. PubMed ID: 13889609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of ionizing irradiations on the process of formation of immunity during immunization with live tularemia vaccine].
    SHEVELEV AS; PRUDNIKOVA MN
    Biull Eksp Biol Med; 1960 May; 49():94-8. PubMed ID: 14445936
    [No Abstract]   [Full Text] [Related]  

  • 19. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the pathogenesis of tularemia. III. Survival of B. tularense in normal and immunized rabbits.
    SKRODZKI E
    Arch Immunol Ther Exp (Warsz); 1961; 9():509-17. PubMed ID: 13913722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.